Annual report pursuant to Section 13 and 15(d)

EQUITY AND EARNINGS PER SHARE - Schedule of Warrants (Details)

v3.20.4
EQUITY AND EARNINGS PER SHARE - Schedule of Warrants (Details) - $ / shares
1 Months Ended 12 Months Ended
May 19, 2020
Feb. 28, 2019
Jan. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Beginning balance, Outstanding options (in shares)       12,808,916 8,498,138
Options granted (in shares)       1,619,739 6,352,000
Exercised (in shares)       0 (2,041,222)
Options expired unexercised (in shares)       0 0
Ending balance, Outstanding options (in shares)       14,428,655 12,808,916
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Weighted average exercise price, options granted (in dollars per share)       $ 17.41 $ 16.20
Exercised (in dollars per share)       $ 0 $ (13.88)
Share-based Payment Arrangement, Nonemployee          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Options granted (in shares)   4,600,000 2,900,000    
Share-based Payment Arrangement, Nonemployee | Warrant          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Beginning balance, Outstanding options (in shares)       0  
Options granted (in shares) 43,400,000     43,400,000  
Exercised (in shares)       0  
Options expired unexercised (in shares)       0  
Ending balance, Outstanding options (in shares)       43,400,000 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Beginning balance, outstanding warrants (in dollars per share)       $ 0  
Weighted average exercise price, options granted (in dollars per share)       6.79  
Exercised (in dollars per share)       0  
Expired (in dollars per share)       0  
Ending balance, outstanding warrants (in dollars per share)       6.79 $ 0
Anti-dilutive adjustment (in dollars per share)       $ 0.10